{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:01:42Z","timestamp":1782932502093,"version":"3.54.5"},"reference-count":121,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Dengue fever is one of the most common viral infections affecting humans. It is an expanding public health problem, particularly in tropical and subtropical regions. No effective vaccine or antiviral therapies against Dengue virus (DENV) infection are available. Therefore, there is a strong need to develop safe and effective therapeutic strategies that can reduce the burden and duration of hospitalizations due to this life-threatening disease. Oligonucleotide-based strategies are considered as an attractive means of inhibiting viral replication since oligonucleotides can be designed to interact with any viral RNA, provided its sequence is known. The resultant targeted destruction of viral RNA interferes with viral replication without inducing any adverse effects on cellular processes. In this review, we elaborate the ribozymes, RNA interference, CRISPR, aptamer and morpholino strategies for the inhibition of DENV replication and discuss the challenges involved in utilizing such approaches.<\/jats:p>","DOI":"10.3390\/molecules26040956","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T18:45:00Z","timestamp":1613155500000},"page":"956","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication"],"prefix":"10.3390","volume":"26","author":[{"given":"Kingshuk","family":"Panda","sequence":"first","affiliation":[{"name":"Dengue &amp; Chikungunya Group, ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1401-8589","authenticated-orcid":false,"given":"Kalichamy","family":"Alagarasu","sequence":"additional","affiliation":[{"name":"Dengue &amp; Chikungunya Group, ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2688-3684","authenticated-orcid":false,"given":"Deepti","family":"Parashar","sequence":"additional","affiliation":[{"name":"Dengue &amp; Chikungunya Group, ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/v10100569","article-title":"Time to harmonize dengue Nomenclature and classification","volume":"10","author":"Libin","year":"2018","journal-title":"Viruses"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05109-0","article-title":"Productivity costs from a dengue episode in Asia: A systematic literature review","volume":"20","author":"Hung","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00705-020-04653-z","article-title":"Molecular and evolutionary analysis of dengue virus serotype 2 isolates from Korean travelers in 2015","volume":"165","author":"Hwang","year":"2020","journal-title":"Arch. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Murugesan, A., and Manoharan, M. (2020). Dengue Virus. Emerging and Reemerging Viral Pathogens, Elsevier.","DOI":"10.1016\/B978-0-12-819400-3.00016-8"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M504337200","article-title":"Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals","volume":"280","author":"Lozach","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Carro, A.C., Piccini, L.E., and Damonte, E.B. (2018). Blockade of dengue virus entry into myeloid cells by endocytic inhibitors in the presence or absence of antibodies. PLoS Negl. Tropical. Dis., 12.","DOI":"10.1371\/journal.pntd.0006685"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Marchiori, E., Hochhegger, B., and Zanetti, G. (2020). Pulmonary manifestations of dengue. J. Bras. Pneumol., 46.","DOI":"10.1590\/1806-3713\/e20190246"},{"key":"ref_8","unstructured":"World Health Organization (2014). Dengue and Severe Dengue, World Health Organization, Regional Office for the Eastern Mediterranean."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2174\/0929866525666180709115506","article-title":"Molecular aspects of the dengue virus infection process: A review","volume":"25","author":"Zonetti","year":"2018","journal-title":"Protein Pept. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"561366","DOI":"10.3389\/fcimb.2020.561366","article-title":"Role of platelet cytokines in Dengue virus infection","volume":"10","author":"Singh","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40506-019-00193-6","article-title":"Therapeutics for Dengue","volume":"11","author":"Masri","year":"2019","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/infdis\/jiw423","article-title":"Current status of dengue therapeutics research and development","volume":"215","author":"Low","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.18433\/jpps30216","article-title":"Current prevention and potential treatment options for dengue infection","volume":"22","author":"Jasamai","year":"2019","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coviro.2020.09.004","article-title":"Dengue vaccine development by the year 2020: Challenges and prospects","volume":"43","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1080\/21645515.2019.1658503","article-title":"A review of Dengvaxia\u00ae: Development to deployment","volume":"15","author":"Thomas","year":"2019","journal-title":"Hum. Vaccin Immunother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/1386207319666160506123715","article-title":"An in-silico investigation of phytochemicals as antiviral agents against dengue fever","volume":"19","author":"Powers","year":"2016","journal-title":"Comb. Chem High. Throughput Screen."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"016","DOI":"10.7324\/JAPS.2020.10503","article-title":"Exploration of bioflavonoids targeting dengue virus NS5 RNA-dependent RNA polymerase: In silico molecular docking approach","volume":"10","author":"Sivaraman","year":"2020","journal-title":"J. App. Pharm. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tricou, V., Minh, N.N., Van, T.P., Lee, S.J., Farrar, J., Wills, B., Tran, H.T., and Simmons, C.P. (2010). A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLos Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000785"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients","volume":"207","author":"Nguyen","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/1389200219666180129145252","article-title":"Medicinal and therapeutic potential of herbs and plant metabolites\/extracts countering viral pathogens-current knowledge and future prospects","volume":"19","author":"Dhama","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1093\/nar\/gkz737","article-title":"Novel ribozymes: Discovery, catalytic mechanisms, and the quest to understand biological function","volume":"47","author":"Weinberg","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1574-6976.1999.tb00399.x","article-title":"Ribozymes: The characteristics and properties of catalytic RNAs","volume":"23","author":"Tanner","year":"1999","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0966-842X(00)88927-1","article-title":"The potential of ribozymes as antiviral agents","volume":"3","author":"Sczakiel","year":"1995","journal-title":"Trends Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02762337","article-title":"Antiviral ribozymes","volume":"8","author":"Menke","year":"1997","journal-title":"Mol. Biotechnol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-409X(00)00085-5","article-title":"Ribozyme therapy for HIV infection","volume":"44","author":"Rossi","year":"2000","journal-title":"Adv Drug Deliv. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e1466","DOI":"10.1002\/wrna.1466","article-title":"Therapeutic applications of group I intron-based trans-splicing ribozymes","volume":"9","author":"Lee","year":"2018","journal-title":"Wiley Interdiscip Rev. RNA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1743-422X-6-73","article-title":"Effective suppression of Dengue fever virus in mosquito cell cultures using retroviral transduction of hammerhead ribozymes targeting the viral genome","volume":"6","author":"Nawtaisong","year":"2009","journal-title":"Virol. J."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Carter, J.R., Keith, J.H., Barde, P.V., Fraser, T.S., and Fraser, M.J. (2010). Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns. BMC Mol. Biol., 11.","DOI":"10.1186\/1471-2199-11-84"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-11-111","article-title":"Effective suppression of dengue virus using a novel group-I intron that induces apoptotic cell death upon infection through conditional expression of the Bax C-terminal domain","volume":"11","author":"Carter","year":"2014","journal-title":"Virol. J."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Carter, J.R., Taylor, S., Fraser, T.S., Kucharski, C.A., Dawson, J.L., and Fraser Jr, M.J. (2015). Suppression of the arboviruses dengue and chikungunya using a dual-acting group-I intron coupled with conditional expression of the Bax C-terminal domain. PLoS ONE., 10.","DOI":"10.1371\/journal.pone.0139899"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2307\/3869076","article-title":"Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans","volume":"2","author":"Napoli","year":"1990","journal-title":"Plant. Cell."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1096\/fj.06-6014rev","article-title":"A brief history of RNAi: The silence of the genes","volume":"20","author":"Sen","year":"2006","journal-title":"FASEB J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1976","DOI":"10.1002\/rmv.1976","article-title":"A review on current status of antiviral siRNA","volume":"28","author":"Qureshi","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA versus miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S2221-1691(13)60057-X","article-title":"RNAi: Antiviral therapy against dengue virus","volume":"3","author":"Idrees","year":"2013","journal-title":"Asian Pac. J. Trop Biomed."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","article-title":"RNA interference: Biology, mechanism, and applications","volume":"67","author":"Agrawal","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"105159","DOI":"10.1016\/j.ejps.2019.105159","article-title":"Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use","volume":"142","author":"Parashar","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-0556-2-8","article-title":"Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery","volume":"2","author":"Zhang","year":"2004","journal-title":"Genet. Vaccines Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1128\/JVI.02105-08","article-title":"Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production","volume":"84","author":"Subramanya","year":"2010","journal-title":"J Virol."},{"key":"ref_40","first-page":"373","article-title":"Study on the inhibitory effect of RNA interference on replication of dengue virus","volume":"26","author":"Yue","year":"2010","journal-title":"Bing Du Xue Bao."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1128\/JVI.05298-11","article-title":"Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence","volume":"85","author":"Stein","year":"2011","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1743-422X-7-24","article-title":"Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus","volume":"7","author":"Ang","year":"2010","journal-title":"Virol. J."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Alhoot, M.A., Wang, S.M., and Sekaran, S.D. (2012). RNA interference mediated inhibition of dengue virus multiplication and entry in HepG2 cells. PLoS ONE., 7.","DOI":"10.1371\/journal.pone.0034060"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.6026\/97320630008519","article-title":"Bioinformatics prediction of siRNAs as potential antiviral agents against dengue viruses","volume":"8","year":"2012","journal-title":"Bioinformation."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00705-018-3757-2","article-title":"Inhibition of dengue virus infection by small interfering RNAs that target highly conserved sequences in the NS4B or NS5 coding regions","volume":"163","author":"Villegas","year":"2018","journal-title":"Arch Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/jmv.23815","article-title":"MiR-252 of the Asian tiger mosquito Aedes albopictus regulates dengue virus replication by suppressing the expression of the dengue virus envelope protein","volume":"86","author":"Yan","year":"2014","journal-title":"J Med. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jinf.2014.12.001","article-title":"Cellular microRNA-miR-548g-3p modulates the replication of dengue virus","volume":"70","author":"Wen","year":"2015","journal-title":"J. Infect."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Castillo, J.A., Castrill\u00f3n, J.C., Diosa-Toro, M., Betancur, J.G., St Laurent, G., Smit, J.M., and Urcuqui-Inchima, S.J.B.i.d. (2015). Complex interaction between dengue virus replication and expression of miRNA-133a. BMC Inf Dis., 16.","DOI":"10.1186\/s12879-016-1364-y"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/0074-02760160404","article-title":"Overexpression of miR-484 and miR-744 in Vero cells alters Dengue virus replication","volume":"112","year":"2017","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/ph13080157","article-title":"Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs?","volume":"13","year":"2020","journal-title":"Pharmaceuticals"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/ph9040078","article-title":"Use of aptamers as diagnostics tools and antiviral agents for human viruses","volume":"9","year":"2016","journal-title":"Pharmaceuticals"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.12665\/J114.KedzierskiCaltagirone","article-title":"Synthetic antibodies: The emerging field of aptamers","volume":"11","author":"Kedzierski","year":"2012","journal-title":"BioProcess J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.010909.105547","article-title":"Discovery and development of therapeutic aptamers","volume":"50","author":"Bouchard","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.3390\/molecules15074610","article-title":"In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules","volume":"15","author":"Marton","year":"2010","journal-title":"Molecules"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kulkarni, R. (2020). Antibody-Dependent Enhancement of Viral Infections. Dynamics of Immune Activation in Viral Diseases, Springer.","DOI":"10.1007\/978-981-15-1045-8_2"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"13094","DOI":"10.1128\/JVI.00704-13","article-title":"Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles","volume":"87","author":"Balinsky","year":"2013","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Chen, H.-L., Hsiao, W.-H., Lee, H.-C., Wu, S.-C., and Cheng, J.-W. (2015). Selection and characterization of DNA aptamers targeting all four serotypes of dengue viruses. PLoS ONE., 10.","DOI":"10.1371\/journal.pone.0131240"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10529-017-2462-7","article-title":"Development of RNA aptamer that inhibits methyltransferase activity of dengue virus","volume":"40","author":"Jung","year":"2018","journal-title":"Biotechnol Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6817-6_1","article-title":"Invention and early history of morpholinos: From pipe dream to practical products","volume":"Volume 1565","author":"Summerton","year":"2017","journal-title":"Morpholino Oligomers. Methods in Molecular Biology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/oli.1.1997.7.187","article-title":"Morpholino antisense oligomers: Design, preparation, and properties","volume":"7","author":"Summerton","year":"1997","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2144\/000113005","article-title":"Vivo-Morpholinos: A non-peptide transporter delivers Morpholinos into a wide array of mouse tissues","volume":"45","author":"Morcos","year":"2008","journal-title":"Biotechniques"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3389\/fmicb.2018.00750","article-title":"Antisense phosphorodiamidate morpholino oligomers as novel antiviral compounds","volume":"9","author":"Nan","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1128\/JVI.79.8.5116-5128.2005","article-title":"Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers","volume":"79","author":"Kinney","year":"2005","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.virol.2005.08.034","article-title":"Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3\u2032 stem\u2013loop structure","volume":"344","author":"Holden","year":"2006","journal-title":"Virology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkn221","article-title":"Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus","volume":"62","author":"Stein","year":"2008","journal-title":"J. Antimicrob Chemother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00705-017-3666-9","article-title":"Vivo-morpholino oligomers strongly inhibit dengue virus replication and production","volume":"163","author":"Phumesin","year":"2018","journal-title":"Arch. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.virusres.2018.11.014","article-title":"Inhibition of dengue virus replication in monocyte-derived dendritic cells by vivo-morpholino oligomers","volume":"260","author":"Phumesin","year":"2019","journal-title":"Virus Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"591","DOI":"10.15171\/apb.2018.067","article-title":"The impact of crispr-cas system on antiviral therapy","volume":"8","author":"Bayat","year":"2018","journal-title":"Adv. Pharm Bull."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature18625","article-title":"A CRISPR screen defines a signal peptide processing pathway required by flaviviruses","volume":"535","author":"Zhang","year":"2016","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.celrep.2016.06.028","article-title":"Identification of Zika virus and dengue virus dependency factors using functional genomics","volume":"16","author":"Savidis","year":"2016","journal-title":"Cell Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nature18631","article-title":"Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens","volume":"535","author":"Marceau","year":"2016","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nature24049","article-title":"RNA targeting with CRISPR\u2013Cas13","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Kumar, N., and Marx, D. (2020). Deciphering the Self-Cleavage Reaction Mechanism of Hairpin Ribozyme. J. Phys. Chem B.","DOI":"10.1021\/acs.jpcb.0c03768"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Xu, W., Jiang, X., and Huang, L. (2019). RNA Interference Technology. Compr. Biotechnol., 560\u2013575.","DOI":"10.1016\/B978-0-444-64046-8.00282-2"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.3390\/ijms21228420","article-title":"Methods and Applications of In Silico Aptamer Design and Modeling","volume":"21","author":"Buglak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Perreault, J., Weinberg, Z., Roth, A., Popescu, O., Chartrand, P., Ferbeyre, G., and Breaker, R.R. (2011). Identification of hammerhead ribozymes in all domains of life reveals novel structural variations. PLoS Comput Biol., 7.","DOI":"10.1371\/journal.pcbi.1002031"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1759-8753-4-17","article-title":"Nuclear group I introns in self-splicing and beyond","volume":"4","author":"Hedberg","year":"2013","journal-title":"Mob. DNA."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Svoboda, P. (2020). Key Mechanistic Principles and Considerations Concerning RNA Interference. Front. Plant. Sci., 11.","DOI":"10.3389\/fpls.2020.01237"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/molecules24050941","article-title":"Recent advances in aptamer discovery and applications","volume":"24","author":"Zhang","year":"2019","journal-title":"Molecules"},{"key":"ref_84","first-page":"583","article-title":"Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities","volume":"90","author":"Quijano","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1002\/j.1460-2075.1996.tb00745.x","article-title":"Specificity of hammerhead ribozyme cleavage","volume":"15","author":"Hertel","year":"1996","journal-title":"EMBO J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fmolb.2018.00041","article-title":"Simple methods and rational design for enhancing aptamer sensitivity and specificity","volume":"5","author":"Kalra","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.devcel.2015.09.017","article-title":"Morpholinos: Antisense and sensibility","volume":"35","author":"Blum","year":"2015","journal-title":"Dev. Cell."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1093\/nar\/gkv1111","article-title":"Automated design of hammerhead ribozymes and validation by targeting the PABPN1 gene transcript","volume":"44","author":"Kharma","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-019-0196-3","article-title":"Editorial focus: Understanding off-target effects as the key to successful RNAi therapy","volume":"24","author":"Bartoszewski","year":"2019","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2018.08.005","article-title":"Aptamer-based targeted therapy","volume":"134","author":"Zhu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1242\/dev.001115","article-title":"Controlling morpholino experiments: Don\u2019t stop making antisense","volume":"135","author":"Eisen","year":"2008","journal-title":"Development"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1261\/rna.1161908","article-title":"Potent RNAi by short RNA triggers","volume":"14","author":"Chu","year":"2008","journal-title":"RNA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fmicb.2019.01462","article-title":"Application of aptamers in virus detection and antiviral therapy","volume":"10","author":"Zou","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_94","first-page":"26","article-title":"Using Morpholinos to control gene expression","volume":"83","author":"Moulton","year":"2008","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1016\/S0969-2126(00)00112-X","article-title":"RNA folding: Beyond Watson\u2013Crick pairs","volume":"8","author":"Westhof","year":"2000","journal-title":"Structure"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2144\/000112792","article-title":"RNAi mechanisms and applications","volume":"44","author":"Kim","year":"2008","journal-title":"Biotechniques"},{"key":"ref_97","unstructured":"Hidding, J. (2016). A therapeutic battle: Antibodies vs. Aptamers. Nanosci. Master Program., 1\u201320."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1261\/rna.2256610","article-title":"Morpholino oligonucleotides do not participate perfectly in standard Watson-Crick complexes with RNA","volume":"16","author":"Xiao","year":"2010","journal-title":"RNA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-21153-y","article-title":"Combined aptamer and transcriptome sequencing of single cells","volume":"8","author":"Delley","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/bfgp\/elr021","article-title":"Lessons from morpholino-based screening in zebrafish","volume":"10","author":"Bedell","year":"2011","journal-title":"Brief. Funct Genomics."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1471-4914(01)01965-7","article-title":"Ribozyme gene therapy: Applications for molecular medicine","volume":"7","author":"Lewin","year":"2001","journal-title":"Trends Mol. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1534\/genetics.117.300077","article-title":"RNA interference (RNAi) screening in Drosophila","volume":"208","author":"Heigwer","year":"2018","journal-title":"Genetics"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/genes9110529","article-title":"Aptamer chimeras for therapeutic delivery: The challenging perspectives","volume":"9","author":"Esposito","year":"2018","journal-title":"Genes (Basel)."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"34","DOI":"10.32607\/20758251-2013-5-4-34-43","article-title":"Aptamers: Problems, solutions and prospects","volume":"5","author":"Lakhin","year":"2013","journal-title":"Acta Naturae."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chembiol.2011.12.008","article-title":"RNA-based therapeutics: Current progress and future prospects","volume":"19","author":"Burnett","year":"2012","journal-title":"Chem. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1261\/rna.7288405","article-title":"High-throughput RNAi screening in vitro: From cell lines to primary cells","volume":"11","author":"Ovcharenko","year":"2005","journal-title":"RNA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.sbi.2007.05.003","article-title":"Ribozymes","volume":"17","author":"Scott","year":"2007","journal-title":"Curr. Opin. Struct Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fphys.2016.00553","article-title":"RNAi efficiency, systemic properties, and novel delivery methods for pest insect control: What we know so far","volume":"7","author":"Joga","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/hmg\/7.10.1649","article-title":"Ribozymes as therapeutic tools for genetic disease","volume":"7","author":"Phylactou","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2018.07.008","article-title":"RNAi-mediated antiviral immunity in mammals","volume":"32","author":"Berkhout","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/s120100612","article-title":"Aptamers and their biological applications","volume":"12","author":"Song","year":"2012","journal-title":"Sensors"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/mt.2013.263","article-title":"Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice","volume":"22","author":"Pandey","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"490","DOI":"10.18520\/cs\/v112\/i03\/490-498","article-title":"Antisense oligonucleotides as therapeutics and their delivery","volume":"112","author":"Gurav","year":"2017","journal-title":"Curr. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1021\/bc300128r","article-title":"PEGylation and biodistribution of an anti-MUC1 aptamer in MCF-7 tumor-bearing mice","volume":"23","author":"Blackshaw","year":"2012","journal-title":"Bioconjug Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/AAC.00069-07","article-title":"In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus","volume":"51","author":"Deas","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e02227-14","DOI":"10.1128\/mBio.02227-14","article-title":"Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics","volume":"6","author":"Kugelman","year":"2015","journal-title":"mBio"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3390\/molecules24162908","article-title":"Impact of the Position of the Chemically Modified 5-Furyl-2\u2032-Deoxyuridine Nucleoside on the Thrombin DNA Aptamer\u2013Protein Complex: Structural Insights into Aptamer Response from MD Simulations","volume":"24","author":"Manderville","year":"2019","journal-title":"Molecules"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/molecules25071526","article-title":"Discovery, Design, Synthesis, and Application of Nucleoside\/Nucleotides","volume":"25","year":"2020","journal-title":"Molecules"},{"key":"ref_119","first-page":"9587","article-title":"Selection of 2\u2032-deoxy-2\u2032-fluoroarabinonucleotide (FANA) aptamers that bind HIV-1 reverse transcriptase with picomolar affinity","volume":"43","author":"Cozens","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1093\/nar\/gkz252","article-title":"Highly stable hexitol based XNA aptamers targeting the vascular endothelial growth factor","volume":"47","author":"Eremeeva","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"a032490","DOI":"10.1101\/cshperspect.a032490","article-title":"Beyond DNA and RNA: The expanding toolbox of synthetic genetics","volume":"11","author":"Taylor","year":"2019","journal-title":"Cold Spring Harb Perspect Biol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/4\/956\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:22:55Z","timestamp":1760160175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/4\/956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":121,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["molecules26040956"],"URL":"https:\/\/doi.org\/10.3390\/molecules26040956","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]}}}